Free CEUs for Pharmacists

Treating Dry Eye: The Pharmacist's Role

2017-03-14T12:10:00.000-04:00

Feeling the Burn - The Pharmacist's Role in Treating Dry Eye- Dry eye disease is a common ocular condition affecting millions of Americans. With this condition, there is most often an insufficient amount of tears to lubricate and nourish the eye. Tears are essential for ensuring the health of the front surface of the eye and maintaining clear vision. Dry eye can cause irritation and lead to complications of the ocular surface, thus appropriate diagnosis and treatment is essential. Topical treatment includes numerous over the counter drops as well as prescription medications. A majority of the patients have milder or episodic symptoms, which will respond to the over-the-counter artificial tear supplements. Since patients frequently self-treat, pharmacists should have an understanding of the symptoms and treatments for dry eye and be prepared to discuss treatment options with patients who do not adequately respond to artificial tears. This program not only gives the pharmacist a solid knowledge base to make appropriate treatment recommendations for patients presenting wi th the signs and symptoms of dry eye but also identifies the point when a timely referral to an eye care specialist is appropriate. Review the basics of dry eye including symptoms and causes. Describe the FDA approved over-the-counter and prescription medications available to treat dry eye disease to include mechanism of action and side effects. Outline key considerations regarding appropriate over-the-counter or prescription treatment and/or for referring patients to an eye care provider when appropriate.

1.0 Free CEUs for Pharmacists and Pharmacy Techs

Expires 6/20/17

financial support by Shire Pharmaceuticals

Contraceptives: A Call for Pharmacists to Communicate With Patients

2016-11-27T13:55:00.000-05:00

Contraceptives: A Call for Pharmacists to Rethink and Engage in Communication with Patients- Identify various forms of currently available contraceptives and their effectiveness. Given a specific patient history, compare and contrast various contraceptives to determine the most appropriate contraceptive for a patient. Review appropriate screening, initiation and continuation of various contraceptives, including intrauterine devices, implants, and combined hormonal contraceptives (pills, ring, patch). Design a therapeutic plan to manage the most common side effects associated with combined hormonal contraceptives.

1.0 Free CEUs for Pharmacists and Pharmacy Techs

Expires 4/25/19

Financial support by Merck

Guidelines for Managing Chemotherapy-induced Nausea and Vomiting

2016-10-21T13:02:00.000-04:00

Chemotherapy-induced Nausea and Vomiting: The Pharmacist’s Role in Integrating Clinical Guidelines into Patient Care- Evaluate new and revised strategies for Chemotherapy-induced Nausea and Vomiting (CINV) management based on emerging data and updates to national and international guidelines. Review the data supporting the use of individual antiemetic agents and combinations for patients on moderately- and highly-emetogenic regimens, including emerging agents. Develop a plan for adequate antiemetic prophylaxis and breakthrough treatment based on antiemetic drug classifications. Using patient cases, design optimal guideline-based approaches for the prevention and management of CINV for patients at risk for developing acute and delayed-onset CINV taking into consideration patient- and regimen-specific characteristics.

1.0 Free CEUs for Pharmacists

Expires 5/18/17

Immunosuppression and Transplant Medicine

2016-08-08T12:17:00.002-04:00

A Balancing Act: Immunosuppression in Transplant Medicine- The current goal of transplant medicine and immunology is to develop strategies to extend the life and functionality of every allograft. Outcomes of renal and liver transplantation have improved; yet, allograft loss remains a substantial problem associated with increased morbidity, mortality, and costs.1 Identifying the pathologic pathways responsible for allograft loss and developing therapeutic interventions is one of the primary challenges in transplant medicine. Education to transplant clinicians about regularly evaluating all of the aspects of post-transplant care that can contribute to allograft dysfunction or loss can improve the patient-provider dialogue to foster adherence to treatment and careful monitoring of medication levels to maintain quality of life. Patient stories, integrated in the symposium design, highlight the challenges and opportunities to coordinate care with patients in alignment with the priorities of the National Quality Strategy. Describe the causes of antibody-mediated complications in kidney and liver transplants. Implement regular monitoring strategies that can optimize appropriate immunosuppression while managing side effects in transplant patients. Engage transplant patients to become participants in their treatment to promote adherence to medications and improve outcomes.

1.25 Free CEUs for Pharmacists

Expires 7/15/17

Advanced Gout Management

2016-05-24T12:19:00.000-04:00

Defining the Role of Pharmacists in Advanced Gout Management- Discuss the pathophysiology of gout, its risk factors, and long-term complications. Outline the clinical profiles of available and emerging gout pharmacotherapies including safety, efficacy, mechanisms-of-action, implications, and potential shortfalls of conventional agents. Assist providers on the guideline-directed and individualized selection, modification, and monitoring of gout therapies. Counsel patients on non-pharmacologic and pharmacologic approaches to care, emphasizing the importance of adherence to therapies and lifestyle modifications.

1.0 Free CEUs for Pharmacists

Expires 4/29/17

Supported by an educational grant from AstraZeneca Pharmaceuticals LP.

Advances in the Treatment of Multiple Sclerosis

2016-04-29T12:00:00.000-04:00

Year in Review: Advances in the Treatment of Multiple Sclerosis- Assess the impact of unmet treatment needs for patients with MS. Summarize key recent evidence on the efficacy and safety of emerging therapies for relapsing and progressive forms of MS. Describe the general mechanisms of action for MS therapies that deplete B-cells, sequester T-cells, and promote neuroprotection. Apply evidence from recent clinical trials to guide effective treatment decisions for patients with MS.

1.5 Free CEUs for Pharmacists

This course also offers Free CME for Physicians, PAs, Nurse Practitioners and Nurses

Expires 2/14/17

Expanding Role of Pharmacy in the Treatment of Pulmonary Arterial Hypertension

2016-03-24T12:35:00.000-04:00

Utilizing Patient-Centered Approaches in Pulmonary Arterial Hypertension (PAH): The Expanding Role of Pharmacists- Pulmonary arterial hypertension (PAH) is a rare disease with significant consequences, including serious functional impairment and premature death. If left untreated, PAH is rapidly fatal. Fortunately, over the past decade, the knowledge and understanding of this disease has greatly expanded. Furthermore, the availability of effective and more convenient oral and inhaled medications has allowed clinicians to better individualize therapy to meet patient treatment goals. Though there is no cure for PAH, effective treatment can significantly slow disease progression and clinical worsening. Given the serious nature of this disease and its rapid progression, optimal treatment selection is essential.
The Role of the Pharmacist- Optimal management of patients with PAH requires early detection and diagnosis followed by an aggressive treatment plan. By increasing their competency, pharmacists can play an important role within the multidisciplinary team when encountering patients with this deadly and rapidly progressing disease. Given the complex and individualized nature of PAH therapy, pharmacists must have a full understanding of treatment algorithms, disease-specific therapies, and long-term monitoring recommendations based on evidence-based guidelines. As the armamentarium to treat PAH continues to expand, pharmacists must make efforts to stay informed of the latest findings in order to contribute to the optimal management of these patients.
Explain how treatment algorithms and prognostic factors can be used to individualize care for patients with PAH when selecting initial treatment.
Evaluate the role of the various therapeutic classes in the treatment of PAH, including balancing the benefits and risks of monotherapy versus combination therapy.
Discuss the role of pharmacists as part of the interprofessional healthcare team when managing patients with PAH.

1.5 Free CEUs for Pharmacists

Expires 1/11/17

This activity is jointly provided by Center for Independent Healthcare Education and Vemco MedEd.

U500 Insulin:Getting It Right - Part II

2016-03-12T14:01:00.000-05:00

Safe Use of Concentrated Insulin: Helping Patients and Providers to Get It Right (Part II of II)- Calculate doses of U-500 insulin in “syringe units” for administration using a U-100 syringe, and discuss methods for instructing patients to convert insulin concentrations. Incorporate clinical properties of concentrated insulins when developing patient care plans to ensure safe administration. Discuss strategies for counseling patients who are transitioning from inpatient to outpatient settings to minimize the risk of insulin-administration errors.

1.0 Free CEUs for Pharmacists

Expires 5/15/17

U500 Insulin- Getting It Right

2016-03-03T12:00:00.000-05:00

Safe Use of Concentrated Insulin: Helping Patients and Providers to Get It Right (Part I of II)- The diabetic population continues to grow in the U.S. and worldwide, in tandem with an epidemic of obesity. As a result, insulin resistance is a growing problem, necessitating insulin doses that exceed 200 units per day. The use of highly concentrated insulin to meet glycemic goals has increased dramatically. According to the Institute for Safe Medication Practices, extra caution is needed with concentrated insulin, such as U-500. The ISMP points out that safety concerns with U-500 insulin continue to mount, with increasing reports of medication errors that are largely due to dosing confusion in the absence of a U-500 syringe or pen. Additional insulin strengths – U-200 and U-300 – are in development. Patient education is recognized as the most important aspect of successfully using highly concentrated insulin. Pharmacists must be capable of teaching patients to communicate doses in terms of “syringe units” of U-500 insulin drawn into a U-100 syringe. But first, they must counsel patients to ensure that they understand the difference between U-100 and U-500. Summarize the history and frequency of medication errors that occur with insulin use, including highly concentrated insulin U-500. Explain how to calculate doses of U-500 insulin in “syringe units” for administration using a U-100 syringe and clearly instruct patients to convert insulin concentrations. Discuss the pharmacokinetic, pharmacodynamic, and clinical properties of concentrated insulin, including U-500 and others in development, and factors for safe administration. Describe the role of pharmacists in counseling patients who are transitioning from inpatient to outpatient settings, to minimize the risk of insulin-administration errors and hospital readmissions.

1.0 Free CEUs for Pharmacists

Expires 5/15/17

Pharmaceutical Clean Rooms- Do's & Don'ts

2016-01-19T12:00:00.000-05:00

Clean Room Certification: Do's and Don'ts- Choose a clean room certification vendor based on the specific needs of their clean room. Determine the specific tests needed for the specific clean room layout. Develop checklists to share with the vendor prior to certification. Describe the use of environmental testing, organism identification and what the results mean. Explain the fundamentals of the clean room certification results.

1.0 Free CEUs for Pharmacists

Expires 3/18/16

Oral Anticoagulant Update: Preventing Stroke in Older Adults with Atrial Fibrillation

2016-01-02T11:36:00.000-05:00

Direct-acting Oral Anticoagulants and Guideline Updates: Preventing Stroke in Older Adults With Atrial Fibrillation- Nonvalvular atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice and afflicts more than 3 million people in the United States. AF is an independent risk factor for ischemic stroke severity, recurrence, and mortality. AF is a disease predominantly of older adults: the median age for AF patients is 73 to 75 years. Although most AF-related strokes could be prevented with anticoagulation therapy, many patients with AF are not receiving appropriate evidence-based therapy for stroke prevention. The goal of this monograph is to give consultant pharmacists the tools to overcome barriers to the use of anticoagulation therapy for the prevention of stroke in older adults with AF. Determine when a patient with atrial fibrillation is at risk for stroke using evidence-based risk scoring assessments. Discuss the risk of stroke versus the risk of intracranial bleeding from anticoagulant therapy in patients with AF. Compare the benefits and risks of warfarin and direct-acting oral anticoagulant anticoagulant medications. Discuss reversal agents for non-warfarin anticoagulant medications that are currently under late-stage investigation. Describe a patient who should remain on warfarin therapy and a patient who should be considered for direct-acting oral anticoagulant therapy. Outline current evidence for prescribing aspirin for the prevention of stroke in patients with AF.

1.0 Free CEUs for Pharmacists

Expires 2/20/17

Supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb and Pfizer, Inc. and Daiichi Sankyo, Inc.

Ambulatory Care Pharmacy Practice: An Overview

2015-11-01T10:35:00.000-05:00

Ambulatory Care Pharmacy Practice: Demonstrating Success- This activity provides an overview of how ambulatory care pharmacists demonstrate success in different environments and how success is viewed by various stakeholders. Two successful practice models are discussed in their development and sustainability. Describe sustainable practice models that demonstrate value to stakeholders. Identify specific outcomes in ambulatory pharmacy practice that contribute to improved care delivery. Discuss opportunities for advancing ambulatory pharmacy practice across different practice settings.

1.5 Free CEUs for Pharmacists

Expires 10/21/18

This activity is planned and conducted by ASHP Foundation and ASHP Section of Ambulatory Care Practitioners. It is supported by an educational grant from McKesson.

Inhaled Insulin vs Injectable Insulin

2015-10-22T11:20:00.000-04:00

Inhaled Insulin – A Breath of Fresh Air for the Treatment of Diabetes- Compare the PK/PD profile of inhaled insulin to those of currently available injectable rapid-acting prandial insulins. Review the safety and efficacy data for recently approved inhaled insulin in patients with diabetes. Recognize clinical scenarios in which inhaled insulin would be an appropriate option for managing postprandial glucose excursions in patients with type 1 and type 2 diabetes. Discuss the circumstances when inhaled insulin is contraindicated and the role of pulmonary function testing in patients using inhaled insulin.

1.0 Free CEUs for Pharmacists

Expires 8/7/17

AADE American Assoc of Diabetic Educators This educational program is being supported by an independent educational grant from Sanofi U.S

Emergency Contraception- Who, What, When, Why, & How for Pharmacists

2015-10-02T10:53:00.000-04:00

Emergency Contraception: Clinical Aspects and Patient Care- In recent years, several over-the-counter emergency contraception products have entered the market. These include Plan B and other levonorgestrel-based generic alternatives. No longer are these products dispensed by pharmacists, nor are they subject to age restrictions, counseling requirements, and certain other guidelines that were imposed when Plan B was first approved. Yet, there is significant confusion, as well as misunderstanding and anxiety, among pharmacists as well as consumers regarding how emergency contraception works, when it can be effectively dispensed and used, and who can use it. It is essential that pharmacy professionals be able to consistently and authoritatively counsel patients about OTC emergency contraception products – regardless of whether the product is available OTC, behind-the-counter, or in a locked display. This CE activity provides pharmacists a thorough review of how these products are used, who may purchase them, and how they and their patients can obtain additional needed i nformation. List the currently available emergency contraception (EC) products and their OTC status. Describe the mechanism of action and adverse effects of EC products. Describe how patients obtain EC products, including age restrictions and specific state restrictions. Outline counseling points for patients taking EC products – instructions for use, side effects, and implications. Explain the specific FDA requirements and practice guidelines that govern the sale of EC products.

1.0 Free CEUs for Pharmacists

Expires 6/1/18

Preventing Febrile Neutropenia: Use of Myeloid Growth Factors

2015-09-01T11:04:00.000-04:00

Clinical Pearls for Febrile Neutropenia Prevention: An Algorithmic, Case-Based Guide to Navigating the Use of Myeloid Growth Factors- Identify factors that increase the risk of febrile neutropenia among patients with cancer who are receiving myelosuppressive chemotherapy. Discuss appropriate uses of myeloid CSFs for febrile neutropenia prevention, including dosing and duration of use. Describe strategies to ensure the cost-effective use of myeloid CSFs for febrile neutropenia prevention.

1.0 Free CEUs for Pharmacists Expires 11/20/15

This activity is jointly provided by the University of North Carolina Eshelman School of Pharmacy and Paradigm Medical Communications, LLC

.

Ensuring Appropriate Antibiotic Utilization

2015-08-05T12:20:00.000-04:00

A Pharmacists Guide to Ensuring Appropriate Antibiotic Utilization in Acute Bacterial Skin and Skin-Structure Infections ABSSSIs- Discuss the consequences of overprescribing and inappropriate utilization of antibiotics in the hospital setting. Identify and discuss goals and principles behind rational antibiotic selection in this multidisciplinary approach. Differentiate between directed and empiric antibiotic therapy and explain the place of each in clinical practice. Identify the pharmacist's role in antibiotic stewardship programs, as well as monitoring of associated measurable outcomes. Identify the pharmacist's role in management of ABSSSI, including the use of newer antibiotics.

1.0 Free CEUs for Pharmacists

Expires 5/30/2016

Pharmacy Times

This activity is supported by an educational grant from Cubist Pharmaceuticals, Inc.

Weight Loss & Low Calorie Sweeteners

2015-06-18T12:50:00.000-04:00

Can Low Calorie Sweeteners Help with Weight Management?- Weight management is a perpetual hot topic in scientific circles and the media. When it comes to the role of low-calorie sweeteners, research appears to be mixed. Because research about the impact of low- and no-calorie sweeteners on appetite and food intake frequently appears in the news, healthcare professionals must understand the research to make science-based recommendations that help consumers achieve or maintain a healthy weight. This webinar will review the latest science on low-calorie sweeteners and their impact on diet, appetite and weight management and how clinicians can translate this science into practical applications for helping consumers manage their weight and overall health appropriately and effectively. Identify factors that influence appetite, food intake and eating behavior in human beings that contribute to overweight and obesity. Describe different no and low calorie sweeteners and their distinct features. Evaluate results from studies on the impact of low calorie sweeteners on body weight based on study design. Identify the diet and lifestyle behaviors of people who are regular users of low calorie sweeteners. Inform patients about the role of low calorie sweeteners in the diet.

1.0 Free CEUs for Pharmacists

Free until 12/31/15

Gannet Education

HIV Treatment: Updates to National Guidelines

2015-05-29T12:00:00.000-04:00

Advances in the Treatment of HIV Infection- Describe key updates to national HIV guidelines for initial treatment, use of co-formulations, monitoring treatment responses, and switching antiretroviral therapies. Differentiate the effectiveness of treatment options in HIV and their role in optimizing efficacy, safety, and adherence in HIV-infected patients.

1.0 Free CEUs for Pharmacists

Expires 5/4/16

Understanding Contact Lenses

2015-04-30T12:32:00.000-04:00

The Eyes Have it - Understanding Contact Lens and Appropriate Care - Most schools of pharmacy do not cover the area of ophthalmology to any appreciable extent in the curriculum, so very few practicing pharmacists have a high level of comfort when dealing with issues relating to the contact lens wearers that they may see on a day to day basis. With millions of people wearing contact lenses, pharmacists routinely deal with contact lens-related questions or concerns. While pharmacists don't need to be experts on contact lens, this knowledge based program will give them a basic understanding of contact lens and lens care solution capabilities in order to prepare them to give both schedules and appropriate cleaning techniques. Review the different type of contact lens to include lens care solution compatibilities in order to provide appropriate patient-specific management. Identify the different contact lens complications and appropriate counseling to include timely referral to patient’s eye care professional. Outline appropriate patient counseling strategies to maximize patient lens care compliance while minimizing patient problems and “drop-out rates.

1.0 Free CEUs for Pharmacists

This course also offers Free CEUs for Pharmacy Techs

Expires 10/15/15

Freece.com

Shingles Vaccination Update

2015-04-09T11:35:00.000-04:00

Herpes Zoster Vaccination Clinical Update- The lifetime risk of developing herpes zoster infection (shingles) has been estimated to be approximately 30%. About 20% who get shingles develop post-herpetic neuralgia, a long-lasting pain that is difficult to treat. As the population ages, the number of cases of herpes zoster infection is expected to increase. The herpes zoster vaccine provides an effective and important tool for disease prevention. Yet, barriers to immunization have played a significant factor in limiting its use and effectiveness in preventing disease. Healthcare providers, including primary care, community pharmacists and hospital clinicians, can play a critical role in screening patients and administering the herpes zoster vaccine as a means to improve vaccination rates. To accomplish this, they must not only be knowledgeable about vaccine, but must be aware of the latest recommendations and healthcare policies that can impact vaccine usage.
Identify adult patients who would benefit from herpes zoster vaccination based on current FDA and ACIP immunization guidelines.
Discuss the impact of current healthcare policies on herpes zoster vaccination.
Identify specific considerations when administering the herpes zoster vaccine in various adult populations.

1.5 Free CEUs for Pharmacists

Expires 8/7/15

Paving the Way for Successful Treatment of Schizophrenia

2015-03-29T17:04:00.000-04:00

THE PHARMACIST'S ROLE IN PAVING THE TREATMENT SUCCESS PATHWAY FOR SCHIZOPHRENIA- Differentiate safety, efficacy, pharmacokinetics (PK), and adherence data for the agents used in the long-term maintenance of schizophrenia. Discuss healthcare decision-making and motivation among schizophrenia patients and healthcare providers. Recommend interventions to HCPs that will improve appropriate access to, and use of, antipsychotic medication, including use of LAIs. Perform interventions for schizophrenia patients that will improve appropriate access to, and use of, antipsychotic medication, including use of LAIs.

1.0 Free CEUs for Pharmacists

Expires 6/16/15

Jointly sponsored by RMEI, LLC and The College of Psychiatric and Neurologic Pharmacists. RMEI gratefully acknowledges an educational grant from Otsuka America Pharmaceutical, Inc. and Lundbeck in support of this CPE activity.

Understanding the Basics of Dysphagia

2015-03-06T12:00:00.000-05:00

Dysphagia: Understanding the Basics for Healthcare Professionals- Unmanaged dysphagia can have severe health consequences including malnutrition, dehydration, and aspiration pneumonia. This program begins with the definition of dysphagia and describes the phases of swallowing and how an impaired swallow can have a detrimental effect on nutritional status. Several conditions that are associated with dysphagia are reviewed including nutrition related consequences. A discussion on early identification and intervention is addressed as these steps are key to promoting positive outcomes. Define the phases of swallowing. Identify the risk factors, signs and symptoms of dysphagia. Describe the nutritional management and adaptation of food and beverages for dysphagia management.

1.0 Free CEUs for Pharmacists

Expires 6/1/15

Managing Overweight and Obese Patients

2015-02-06T11:46:00.000-05:00

Obesity Management: Tailoring Treatment to the Needs of the Patient- Outline current guidelines and evidence-based criteria for the management of overweight and obese patients. Assess currently available treatment options for overweight and obese patients and discuss their advantages and disadvantages. Implement current evidenced-based guidelines in the management of overweight and obese patients to devise and tailor treatment plans most suited to the needs of the individual patient. Identify the safety, efficacy, and tolerability profiles of currently available anti-obesity agents and apply the information to select agents that will improve long-term adherence.

1.25 Free CEUs for Pharmacists

Expires 12/31/15

Supported by an educational grant from Eisai.

Addressing Racial Disparities in the Management of Diabetes

2015-01-13T12:58:00.000-05:00

Who's Going to Make the Difference? The Role of Pharmacists in Addressing Disparities in the Management of Diabetes- The existence of disparities in the care of diabetes for certain populations including Latinos/Hispanics, African Americans, Asian Americans, Native Hawaiians and Pacific Islanders and American Indian/Alaskan Natives was identified over twenty years ago. Despite this awareness, disparities have not been adequately addressed and, in some areas, continue to increase. The problem is so serious that the American Diabetes Association made this a 2013 legislative priority and placed it in their 2011-2015 strategic plan. Pharmacists are uniquely placed to address these disparities because of the unparalleled access we have to patients. With the advent of the Affordable Care Act, the time is now for pharmacists to practice at the top of their licenses to address healthcare disparities in diabetes. This program will describe existing healthcare disparities in diabetes, identify those areas where pharmacists can have the greatest impact, and provide practical examples of how pharmacists can develop knowledge and skills to help address health disparities issues. Evaluate the medication therapy and monitoring parameters of a patient with diabetes to ensure that he/she is being treated in accordance with current management practices and guidelines and meeting current goals. Compare and contrast common medication therapy and goal achievement for patients with diabetes with and without health disparities. Develop a plan to address deficits in medication therapy and goal achievement for your patients with health disparities.

1.0 Free CEUs for Pharmacists

This course also offers Free CEUs for Pharmacy Techs

Expires 5/1/15

Presented by FreeCE.com with grant from Merck

Successful Intrathecal Pain Management- Best Practice Strategies

2014-12-12T12:00:00.000-05:00

Strategies for Success in Intrathecal Pain Management- Optimal pain management is a national healthcare priority and we have come a long way in improving the safe and effective use of opioid therapy for patients with both acute and chronic pain. However, for many patients with chronic pain that is severe and intractable, oral opioid therapy is not enough; other options are better suited to achieving pain control. One such option is intrathecal (IT) therapy, which is becoming an increasingly accepted strategy for using both opioid and non-opioid analgesics, and neuromodulators, for the management of intractable pain in appropriate patients. Applying evidence-based patient selection criteria is central to achieving success as are integrating trialing and individualizing the titration schedule for each patient. This replay of a symposium at at national pain meeting will provide the evidence and insight that are warranted to build and strengthen clinicians’ confidence and skill in the use of IT pain therapy. Apply evidence-based, best practice criteria for appropriate patient selection for intrathecal pain management. Implement a slow dose-titration strategy for intrathecal pain management that maximizes efficacy while minimizing the potential for side effects. Integrate evidence-based trialing strategies into the decision-making process when developing an individualized treatment approach to pain management.

1.0 Free CEUs for Pharmacists

Expires 4/30/15

Supported by an educational grant from Jazz Pharmaceuticals, Inc.